Reliq Pb Ratio vs Capex To Depreciation Analysis

RHT Stock

CAD 0.22 0.00 0.00%

Reliq Health financial indicator trend analysis is much more than just breaking down Reliq Health Technologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Reliq Health Technologies is a good investment. Please check the relationship between Reliq Health Pb Ratio and its Capex To Depreciation accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pb Ratio vs Capex To Depreciation

Pb Ratio vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Reliq Health Technologies Pb Ratio account and Capex To Depreciation. At this time, the significance of the direction appears to have no relationship.

The correlation between Reliq Health's Pb Ratio and Capex To Depreciation is 0.09. Overlapping area represents the amount of variation of Pb Ratio that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Reliq Health Technologies, assuming nothing else is changed. The correlation between historical values of Reliq Health's Pb Ratio and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pb Ratio of Reliq Health Technologies are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Pb Ratio i.e., Reliq Health's Pb Ratio and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

0.09

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Pb Ratio

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Reliq Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Reliq Health Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Reliq Health's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 16.73 in 2024, whereas Sales General And Administrative To Revenue is likely to drop 1.28 in 2024.

	2020	2021	2023	2024 (projected)
Cost Of Revenue	604.2K	3.3M	3.7M	3.9M
Research Development	1.7M	2.2M	2.6M	1.7M

Cost Of Revenue Research Development

Reliq Health fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Other Current Liab	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Common Stock	Net Tangible Assets	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Short Term Debt
Total Assets		0.79	0.96	-0.36	-0.75	0.8	0.4	0.41	0.8	0.82	0.66	0.12	0.43	-0.36	0.78	0.96	0.76	0.0	0.73	0.62	0.84	0.96	-0.57	0.13	-0.87	0.51
Total Current Liabilities	0.79		0.58	0.25	-0.9	1.0	-0.2	-0.18	0.97	0.93	0.52	0.35	-0.15	-0.45	1.0	0.65	0.98	-0.39	0.84	0.85	0.95	0.62	-0.65	-0.2	-0.88	0.35
Total Stockholder Equity	0.96	0.58		-0.59	-0.57	0.59	0.62	0.63	0.61	0.64	0.63	-0.01	0.64	-0.27	0.57	0.97	0.55	0.18	0.58	0.42	0.67	0.99	-0.45	0.27	-0.75	0.5
Net Debt	-0.36	0.25	-0.59		-0.15	0.25	-1.0	-1.0	0.26	0.08	-0.25	0.26	-0.98	-0.26	0.26	-0.56	0.29	-0.55	0.28	0.33	0.11	-0.57	-0.13	-0.56	0.03	-0.28
Retained Earnings	-0.75	-0.9	-0.57	-0.15		-0.9	0.09	0.07	-0.84	-0.97	-0.77	-0.55	0.04	0.15	-0.91	-0.65	-0.9	0.23	-0.72	-0.94	-0.96	-0.62	0.4	0.03	0.96	-0.64
Accounts Payable	0.8	1.0	0.59	0.25	-0.9		-0.2	-0.19	0.99	0.93	0.53	0.34	-0.15	-0.49	0.99	0.66	0.98	-0.37	0.86	0.85	0.96	0.63	-0.66	-0.2	-0.89	0.35
Cash	0.4	-0.2	0.62	-1.0	0.09	-0.2		1.0	-0.21	-0.02	0.3	-0.2	0.99	0.26	-0.2	0.6	-0.23	0.53	-0.25	-0.27	-0.05	0.6	0.11	0.55	-0.09	0.33
Cash And Short Term Investments	0.41	-0.18	0.63	-1.0	0.07	-0.19	1.0		-0.2	0.0	0.32	-0.19	0.99	0.26	-0.19	0.61	-0.22	0.53	-0.24	-0.25	-0.03	0.62	0.1	0.56	-0.1	0.35
Net Receivables	0.8	0.97	0.61	0.26	-0.84	0.99	-0.21	-0.2		0.87	0.46	0.25	-0.17	-0.59	0.97	0.65	0.97	-0.41	0.89	0.79	0.93	0.63	-0.68	-0.26	-0.85	0.27
Common Stock Shares Outstanding	0.82	0.93	0.64	0.08	-0.97	0.93	-0.02	0.0	0.87		0.75	0.49	0.03	-0.21	0.94	0.72	0.91	-0.16	0.75	0.92	0.98	0.7	-0.56	0.06	-0.95	0.6
Short Term Investments	0.66	0.52	0.63	-0.25	-0.77	0.53	0.3	0.32	0.46	0.75		0.47	0.34	0.13	0.53	0.66	0.53	0.14	0.45	0.75	0.72	0.68	-0.2	0.31	-0.83	0.88
Inventory	0.12	0.35	-0.01	0.26	-0.55	0.34	-0.2	-0.19	0.25	0.49	0.47		-0.16	0.3	0.38	0.12	0.47	-0.3	0.06	0.59	0.46	0.03	-0.13	-0.19	-0.41	0.51
Other Current Assets	0.43	-0.15	0.64	-0.98	0.04	-0.15	0.99	0.99	-0.17	0.03	0.34	-0.16		0.27	-0.15	0.63	-0.18	0.44	-0.24	-0.23	0.0	0.63	0.09	0.5	-0.13	0.38
Other Stockholder Equity	-0.36	-0.45	-0.27	-0.26	0.15	-0.49	0.26	0.26	-0.59	-0.21	0.13	0.3	0.27		-0.43	-0.24	-0.45	0.25	-0.57	-0.1	-0.3	-0.26	0.43	0.24	0.24	0.48
Total Liab	0.78	1.0	0.57	0.26	-0.91	0.99	-0.2	-0.19	0.97	0.94	0.53	0.38	-0.15	-0.43		0.65	0.98	-0.4	0.83	0.86	0.96	0.61	-0.65	-0.21	-0.88	0.37
Total Current Assets	0.96	0.65	0.97	-0.56	-0.65	0.66	0.6	0.61	0.65	0.72	0.66	0.12	0.63	-0.24	0.65		0.63	0.07	0.52	0.47	0.74	0.98	-0.46	0.21	-0.78	0.53
Other Current Liab	0.76	0.98	0.55	0.29	-0.9	0.98	-0.23	-0.22	0.97	0.91	0.53	0.47	-0.18	-0.45	0.98	0.63		-0.48	0.81	0.85	0.95	0.58	-0.64	-0.31	-0.87	0.37
Property Plant And Equipment Net	0.0	-0.39	0.18	-0.55	0.23	-0.37	0.53	0.53	-0.41	-0.16	0.14	-0.3	0.44	0.25	-0.4	0.07	-0.48		-0.18	-0.23	-0.25	0.16	0.24	0.92	0.13	0.05
Non Current Assets Total	0.73	0.84	0.58	0.28	-0.72	0.86	-0.25	-0.24	0.89	0.75	0.45	0.06	-0.24	-0.57	0.83	0.52	0.81	-0.18		0.76	0.81	0.57	-0.63	-0.13	-0.78	0.27
Non Currrent Assets Other	0.62	0.85	0.42	0.33	-0.94	0.85	-0.27	-0.25	0.79	0.92	0.75	0.59	-0.23	-0.1	0.86	0.47	0.85	-0.23	0.76		0.92	0.47	-0.49	-0.06	-0.89	0.65
Common Stock	0.84	0.95	0.67	0.11	-0.96	0.96	-0.05	-0.03	0.93	0.98	0.72	0.46	0.0	-0.3	0.96	0.74	0.95	-0.25	0.81	0.92		0.71	-0.61	-0.07	-0.96	0.58
Net Tangible Assets	0.96	0.62	0.99	-0.57	-0.62	0.63	0.6	0.62	0.63	0.7	0.68	0.03	0.63	-0.26	0.61	0.98	0.58	0.16	0.57	0.47	0.71		-0.45	0.31	-0.79	0.53
Intangible Assets	-0.57	-0.65	-0.45	-0.13	0.4	-0.66	0.11	0.1	-0.68	-0.56	-0.2	-0.13	0.09	0.43	-0.65	-0.46	-0.64	0.24	-0.63	-0.49	-0.61	-0.45		0.15	0.43	-0.12
Property Plant Equipment	0.13	-0.2	0.27	-0.56	0.03	-0.2	0.55	0.56	-0.26	0.06	0.31	-0.19	0.5	0.24	-0.21	0.21	-0.31	0.92	-0.13	-0.06	-0.07	0.31	0.15		-0.05	0.17
Current Deferred Revenue	-0.87	-0.88	-0.75	0.03	0.96	-0.89	-0.09	-0.1	-0.85	-0.95	-0.83	-0.41	-0.13	0.24	-0.88	-0.78	-0.87	0.13	-0.78	-0.89	-0.96	-0.79	0.43	-0.05		-0.66
Short Term Debt	0.51	0.35	0.5	-0.28	-0.64	0.35	0.33	0.35	0.27	0.6	0.88	0.51	0.38	0.48	0.37	0.53	0.37	0.05	0.27	0.65	0.58	0.53	-0.12	0.17	-0.66

Click cells to compare fundamentals

Reliq Health Account Relationship Matchups

Reliq Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.8M	2.7M	3.5M	10.3M	11.8M	12.4M
Total Current Liabilities	1.1M	1.4M	2.2M	3.7M	4.3M	4.5M
Total Stockholder Equity	2.7M	1.0M	1.0M	6.4M	7.3M	7.7M
Net Debt	(345.0K)	447.2K	176.4K	172.2K	155.0K	162.8K
Retained Earnings	(38.9M)	(49.9M)	(61.7M)	(69.9M)	(62.9M)	(59.7M)
Accounts Payable	904.8K	1.2M	2.1M	3.6M	4.1M	4.3M
Cash	345.0K	12.8K	226.3K	132.8K	152.7K	145.1K
Cash And Short Term Investments	468.0K	135.8K	326.3K	232.8K	267.7K	254.3K
Net Receivables	608.8K	1.0M	2.2M	6.4M	7.3M	7.7M
Common Stock Shares Outstanding	118.4M	135.2M	157.9M	183.1M	210.5M	221.1M
Liabilities And Stockholders Equity	3.8M	2.7M	3.5M	10.3M	11.8M	12.4M
Other Current Assets	79.7K	97.3K	144.6K	102.6K	118.0K	112.1K
Other Stockholder Equity	10.1M	10.7M	12.9M	144K	165.6K	157.3K
Total Liab	1.1M	1.7M	2.5M	3.9M	4.5M	4.7M
Total Current Assets	1.2M	2.4M	3.2M	7.0M	8.0M	8.4M
Other Current Liab	144.7K	195.9K	2.1M	3.6M	4.1M	4.3M
Non Current Assets Total	2.5M	346.1K	283.7K	3.3M	3.8M	4.0M
Accumulated Other Comprehensive Income	10.1M	10.7M	12.9M	13.5M	15.5M	16.3M
Common Stock	31.5M	40.2M	49.8M	62.6M	72.0M	75.6M
Net Tangible Assets	2.8M	1.0M	1.0M	6.4M	7.3M	7.7M
Net Invested Capital	2.7M	1.0M	1.0M	6.4M	5.8M	3.1M
Net Working Capital	126.9K	938.9K	939.9K	3.3M	2.9M	2.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Reliq Stock Analysis

When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC